Expert Video - How does targeted therapy impact AML remission?
In this video, acute myeloid leukemia (AML) experts Dr. Jamile Shammo and Dr. Barry Skikne explain how targeted therapy impacts AML remission. Targeted therapy is a cancer treatment that can "target" specific mutations in an individual's leukemia. The experts describe how targeted therapy is being explored in various combinations to treat AML to achieve remission and prevent or delay relapse.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.